Literature DB >> 1902375

Management of dysthyroid eye disease.

P Fells1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902375      PMCID: PMC1042333          DOI: 10.1136/bjo.75.4.245

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  Botulinum toxin therapy in dysthyroid strabismus.

Authors:  C J Lyons; S F Vickers; J P Lee
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

2.  Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Ophthalmology       Date:  1990-05       Impact factor: 12.079

3.  Prognostic factors in the radiotherapy of Graves' ophthalmopathy.

Authors:  I A Petersen; J P Kriss; I R McDougall; S S Donaldson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-08       Impact factor: 7.038

4.  Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X.

Authors:  A N Harnett; D Doughty; A Hirst; P N Plowman
Journal:  Br J Ophthalmol       Date:  1988-04       Impact factor: 4.638

5.  Orbital decompression for severe dysthyroid eye disease.

Authors:  P Fells
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

6.  Eyelid and orbital fascial attachments and their clinical significance.

Authors:  L Koornneef
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

7.  Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

Authors:  P Kendall-Taylor; A L Crombie; A M Stephenson; M Hardwick; K Hall
Journal:  BMJ       Date:  1988-12-17

8.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

  8 in total
  2 in total

1.  Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy.

Authors:  M F Prummel; W M Wiersinga; R Van der Gaag; M P Mourits; L Koornneef
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

Review 2.  Management of Thyroid Eye Disease-Related Strabismus.

Authors:  Mohammad Reza Akbari; Arash Mirmohammadsadeghi; Raziyeh Mahmoudzadeh; Amirreza Veisi
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.